Animal health risks associated with the transportation and utilisation of wildlife products.

The animal health risks associated with the movement of wildlife products are infinitely less than those associated with the movement of live animals. Very few pathogens are sufficiently robust to survive the significant changes in temperature, pH, moisture content and osmolality which occur post mortem, or which are associated with preservation processes such as pickling, smoking or drying. Certain pathogens, however, (e.g. foot and mouth disease, classical swine fever [hog cholera] and African swine fever viruses and the anthrax bacillus) are hardy and resistant to these environmental changes and therefore constitute a finite animal health risk if raw, undercooked or under-preserved products from infected wild animals are imported. Other less robust pathogens, such as rinderpest virus, may remain infectious in animal products if these are obtained from acutely infected animals and frozen immediately. Macroparasitic diseases such as trichinellosis and echinococcosis-hydatidosis, if present in the unprocessed tissues of infected wildlife, are potentially infectious to carnivorous or omnivorous companion animals. The importation of untreated wet hides may result in the introduction of alien ectoparasites and/or the infectious diseases for which they are vectors. The author discusses the more significant pathogens found in free-ranging wildlife which should be taken into consideration when importing wildlife products from endemically or epidemically infected countries.

Trial of a capripoxvirus-rinderpest recombinant vaccine in African cattle.

Cattle were vaccinated with differing doses of an equal mixture of capripox-rinderpest recombinant viruses expressing either the fusion protein (F) or the haemagglutinin protein (H) of rinderpest virus. Animals vaccinated with 2 x 10(4) p.f.u. or greater of the combined viruses were completely protected against challenge, 1 month later, with both virulent rinderpest and lumpy skin disease viruses. Vaccination with any of the doses did not induce any adverse clinical response in the animals or transmission of the vaccine virus between animals. All cattle challenged 6 or 12 months after vaccination with 2 x 10(5) p.f.u. of the mixture of recombinant viruses were protected from severe rinderpest disease. Ten out of 18 were completely protected while the remaining 8 developed mild clinical signs of rinderpest. Cattle vaccinated with the recombinant vaccines after prior infection with the parental capripox virus showed more marked clinical signs of rinderpest after challenge with virulent rinderpest, but 9 out of 10 recovered, compared with 80% mortality in the unvaccinated controls.